Nuvalent, Inc. (NUVL)
2025-06-30 | ||||
|---|---|---|---|---|
| Unrealized gains (losses) on marketable securities | 509 | |||
| Income tax provision | 145 | |||
| Research and development | 80,913 | |||
| General and administrative | 23,658 | |||
| Total operating expenses | 104,571 | |||
| Loss from operations | -104,571 | |||
| Change in fair value of related party revenue share liability | -6,040 | |||
| Interest income and other income (expense), net | 11,103 | |||
| Total other income (expense), net | 5,063 | |||
| Loss before income taxes | -99,508 | |||
| Net loss | -99,653 | |||
| Comprehensive loss | -99,144 | |||
| Net loss per share attributable to class a and class b common stockholders, basic | -1.39 | |||
| Net loss per share attributable to class a and class b common stockholders, diluted | -1.39 | |||
| Weighted average number of shares outstanding, diluted | 71,843,774 | |||
| Weighted average shares of class a and class b common stock outstanding, basic | 71,843,774 | |||